Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2023-02-10
Original market date: See footnote 1
2001-05-04
Product name:
SOFRAMYCIN NASAL SPRAY
DIN:
02224860
Product Monograph/Veterinary Labelling:
Date:
2023-02-08
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SEARCHLIGHT PHARMA INC
1600 Rue Notre Dame Ouest, Suite 312
Montreal
Quebec
Canada
H3J 1M1
Class:
Human
Dosage form(s):
Spray
Route(s) of administration:
Nasal
Number of active ingredient(s):
3
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:32.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
R01AB01 PHENYLEPHRINE
Active ingredient group (AIG) number:See footnote5
0300763001
Active ingredient(s) See footnote8 | Strength |
---|---|
FRAMYCETIN SULFATE | 12.5 MG / ML |
GRAMICIDIN | 0.05 MG / ML |
PHENYLEPHRINE HYDROCHLORIDE | 2.5 MG / ML |